Advancing medicine, improving lives.
Tulkpharma develops, manufactures and delivers high-quality medicines across the therapeutic areas that matter most — trusted by clinicians and patients in more than 30 markets.
Tulkapharma
Therapeutic areas we serve
Cardiovascular
Therapies for hypertension, heart failure and lipid management.
ExploreAnti-Infectives
Broad and targeted antibiotics and antimicrobials.
ExploreNeurology & CNS
Treatments for pain, epilepsy and neurological disorders.
ExploreGastroenterology
Acid-related and digestive health solutions.
ExploreRespiratory
Relief and management for respiratory conditions.
ExploreWomen's Health
Supplements and therapies supporting women at every stage.
ExploreA pharmaceutical company built on trust
For over two decades, Tulkpharma has combined rigorous science, world-class manufacturing and a patient-first mindset to bring safe, effective and affordable medicines to the people who need them. From our WHO-GMP facilities we produce a broad portfolio spanning chronic and acute care.
Mission
To improve quality of life by making trusted medicines accessible to every patient.
Vision
To be the most trusted pharmaceutical partner across the region.
Selected products
Cardiovita 10
Once-daily calcium-channel blocker for hypertension and angina.
Amoxitulk 500
Broad-spectrum penicillin antibiotic for common infections.
Neurocalm 75
For neuropathic pain and generalized anxiety.
Gastrotulk 40
Proton-pump inhibitor for reflux and ulcers.
Bronchotulk
Mucolytic syrup that eases chesty coughs.
Femtulk Plus
Daily supplement supporting women and pregnancy.
Latest from the newsroom
Tulkpharma commissions new WHO-GMP production line
A €12M investment expands capacity for solid-dose manufacturing.
Cardiovita approved in three new markets
Regulatory clearance extends access for hypertension patients.
Tulkpharma partners with university hospitals on research
A new collaboration accelerates clinical studies across the region.
Looking for a reliable pharmaceutical partner?
Talk to our team about distribution, licensing and manufacturing partnerships.